Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Apr 2024. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5315254011 | Product containing precisely lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 milligram/1 milliliter and naphazoline nitrate 200 microgram/1 milliliter conventional release oromucosal solution (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5315255012 | Lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 mg/mL and naphazoline nitrate 200 microgram/mL oromucosal solution | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 milligram/1 milliliter and naphazoline nitrate 200 microgram/1 milliliter conventional release oromucosal solution (clinical drug) | Has manufactured dose form | Oromucosal solution | true | Inferred relationship | Some | ||
Product containing precisely lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 milligram/1 milliliter and naphazoline nitrate 200 microgram/1 milliliter conventional release oromucosal solution (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 milligram/1 milliliter and naphazoline nitrate 200 microgram/1 milliliter conventional release oromucosal solution (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
Product containing precisely lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 milligram/1 milliliter and naphazoline nitrate 200 microgram/1 milliliter conventional release oromucosal solution (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 2 | |
Product containing precisely lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 milligram/1 milliliter and naphazoline nitrate 200 microgram/1 milliliter conventional release oromucosal solution (clinical drug) | Has precise active ingredient | Lidocaine hydrochloride | true | Inferred relationship | Some | 1 | |
Product containing precisely lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 milligram/1 milliliter and naphazoline nitrate 200 microgram/1 milliliter conventional release oromucosal solution (clinical drug) | Has basis of strength substance (attribute) | Lidocaine hydrochloride anhydrous (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 milligram/1 milliliter and naphazoline nitrate 200 microgram/1 milliliter conventional release oromucosal solution (clinical drug) | Has precise active ingredient | Naphazoline nitrate (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 milligram/1 milliliter and naphazoline nitrate 200 microgram/1 milliliter conventional release oromucosal solution (clinical drug) | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 2 | |
Product containing precisely lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 milligram/1 milliliter and naphazoline nitrate 200 microgram/1 milliliter conventional release oromucosal solution (clinical drug) | Is a | Product containing only lidocaine and naphazoline in oromucosal dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing precisely lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 milligram/1 milliliter and naphazoline nitrate 200 microgram/1 milliliter conventional release oromucosal solution (clinical drug) | Has basis of strength substance (attribute) | Naphazoline nitrate (substance) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets